Journey of a spin off company | Fundraising | Life sciences organisations

Published: Oct. 26, 2020, noon

Life Sciences Leaders series podcast, we will be talking to a variety of senior leaders covering topics that are relevant to what is happening in the industry right now.

In episode 4 of Life Science Leader, we speak with Mike Karim the CEO of Oxford Endovascular. We discuss the journey of a spin out company in the life science sector. 

He knew when they were spinning out that they had had great technology. Mike also knew he had to have a fantastic team that would help develop the concept further to be successful.

Listen to our new podcast, Life Science Leaders, to hear more about life in a spin out company and its many challenges including fundraising.